Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco Dorsey Wright Momentum ETF
PDP
|
+$591M |
| 2 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$240M |
| 3 |
Boston Scientific
BSX
|
+$194M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$193M |
| 5 |
Clarivate
CLVT
|
+$158M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.25B |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$809M |
| 3 |
Willis Towers Watson
WTW
|
+$664M |
| 4 |
AstraZeneca
AZN
|
+$658M |
| 5 |
Microsoft
MSFT
|
+$573M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.19% |
| 2 | Financials | 6.48% |
| 3 | Consumer Discretionary | 5.4% |
| 4 | Healthcare | 5.05% |
| 5 | Communication Services | 4.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2176
CALL
Prologis
PLD
$135B
| $3.01M | ﹤0.01% |
24,000
-20,000
| -45% | -$2.6M |
|
2177
State Street SPDR S&P Dividend ETF
SDY
$23.6B
| $3.01M | ﹤0.01% |
25,587
-57,926
| -69% | -$7.09M |
|
2178
First Trust Smith Opportunistic Fixed Income ETF
FIXD
$3.23B
| $3M | ﹤0.01% |
56,012
+5,191
| +10% | +$280K |
|
|
FOLD
2179
DELISTED
Amicus Therapeutics
FOLD
| $3M | ﹤0.01% |
313,881
-191,924
| -38% | -$1.96M |
|
2180
ACI Worldwide
ACIW
$5.83B
| $3M | ﹤0.01% |
97,478
-23,509
| -19% | -$780K |
|
2181
Hilltop Holdings
HTH
$2.28B
| $3M | ﹤0.01% |
91,677
-29,774
| -25% | -$987K |
|
|
ACBI
2182
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
| $2.99M | ﹤0.01% |
112,971
+112,035
| +11,970% | +$2.73M |
|
2183
CALL
Centene
CNC
$31.5B
| $2.99M | ﹤0.01% |
48,000
-25,000
| -34% | -$1.67M |
|
2184
InterDigital
IDCC
$7.98B
| $2.99M | ﹤0.01% |
44,089
-157,331
| -78% | -$10.9M |
|
|
SF
2185
Stifel
SF
$12.7B
| $2.99M | ﹤0.01% |
65,934
-109,646
| -62% | -$4.89M |
|
2186
C4 Therapeutics
CCCC
$387M
| $2.98M | ﹤0.01% |
66,764
-8,728
| -12% | -$374K |
|
2187
Astrana Health
ASTH
$1.78B
| $2.98M | ﹤0.01% |
32,735
+23,564
| +257% | +$2M |
|
2188
CALL
Liberty Global Class A
LBTYA
$3.71B
| $2.98M | ﹤0.01% |
100,000
-100,000
| -50% | -$2.77M |
|
|
SLCA
2189
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $2.97M | ﹤0.01% |
372,227
-403,894
| -52% | -$3.82M |
|
2190
PUT
Coherent
COHR
$56.4B
| $2.97M | ﹤0.01% |
+50,000
| New | +$3.26M |
|
2191
WEX
WEX
$6.38B
| $2.97M | ﹤0.01% |
16,852
-171,167
| -91% | -$31.2M |
|
2192
iShares US Equity Factor ETF
LRGF
$3.63B
| $2.97M | ﹤0.01% |
70,408
-2,801
| -4% | -$123K |
|
2193
Vanguard Long-Term Bond ETF
BLV
$5.71B
| $2.96M | ﹤0.01% |
28,938
-3,867
| -12% | -$406K |
|
2194
Nabors Industries
NBR
$1.25B
| $2.96M | ﹤0.01% |
30,663
-7,752
| -20% | -$674K |
|
2195
MacroGenics
MGNX
$243M
| $2.96M | ﹤0.01% |
141,122
-49,457
| -26% | -$1.19M |
|
2196
State Street Communication Services Select Sector SPDR ETF
XLC
$22.4B
| $2.96M | ﹤0.01% |
36,892
-32,001
| -46% | -$2.65M |
|
2197
KB Financial Group
KB
$42.2B
| $2.95M | ﹤0.01% |
63,634
-17,553
| -22% | -$794K |
|
2198
Wingstop
WING
$3.55B
| $2.94M | ﹤0.01% |
17,962
+4,348
| +32% | +$737K |
|
2199
Cognyte Software
CGNT
$676M
| $2.94M | ﹤0.01% |
143,282
+129,738
| +958% | +$3.32M |
|
2200
Columbia Banking Systems
COLB
$8.91B
| $2.94M | ﹤0.01% |
77,344
-7,938
| -9% | -$283K |
|
Similar funds
Citigroup's Q3 2021 Portfolio in Review
As of Q3 2021, Citigroup held 6,611 positions worth $169B, up 1.9% from $166B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Citigroup deployed $5.8B of net new capital in Q3 2021, opening 423 new positions and adding to 2,034 existing holdings. Its largest new stake was Hennessy Capital Investment Corp. VI Unit: 9,095,000 shares worth $90.5M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.25B trimmed.
- Citigroup's largest Q3 2021 buy was Hennessy Capital Investment Corp. VI Unit: 9,095,000 shares worth $90.5M.
- Citigroup added most to Invesco Dorsey Wright Momentum ETF in Q3 2021, an estimated $591M increase.
- Citigroup's biggest Q3 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.25B.
- Citigroup fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $809M.
- Citigroup's ten largest holdings make up 25% of its $169B portfolio in Q3 2021.
- Citigroup opened 423 new positions and closed 793 in Q3 2021.
- Citigroup's portfolio value rose 1.9% quarter-over-quarter to $169B.
Based on Citigroup's 13F filing for Q3 2021, filed 10 Nov 2021.